Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

NewAmsterdam Pharma Co N.V (NAMS) Assets Average: 2024-2025

Historic Assets Average for NewAmsterdam Pharma Co N.V (NAMS) over the last 2 years, with Sep 2025 value amounting to $800.8 million.

  • NewAmsterdam Pharma Co N.V's Assets Average rose 80.78% to $800.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $800.8 million, marking a year-over-year increase of 80.78%. This contributed to the annual value of $605.9 million for FY2024, which is 248.57% up from last year.
  • NewAmsterdam Pharma Co N.V's Assets Average amounted to $800.8 million in Q3 2025, which was down 1.96% from $816.8 million recorded in Q2 2025.
  • Over the past 5 years, NewAmsterdam Pharma Co N.V's Assets Average peaked at $841.5 million during Q1 2025, and registered a low of $417.8 million during Q1 2024.
  • Over the past 2 years, NewAmsterdam Pharma Co N.V's median Assets Average value was $651.9 million (recorded in 2024), while the average stood at $634.2 million.
  • Data for NewAmsterdam Pharma Co N.V's Assets Average shows a peak YoY skyrocketed of 101.43% (in 2025) over the last 5 years.
  • Over the past 2 years, NewAmsterdam Pharma Co N.V's Assets Average (Quarterly) stood at $651.9 million in 2024, then spiked by 80.78% to $800.8 million in 2025.
  • Its Assets Average was $800.8 million in Q3 2025, compared to $816.8 million in Q2 2025 and $841.5 million in Q1 2025.